Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Biomarker Study of STA9090 in Castration-Resistant Prostate Cancer (CRPC) With Assessment of Androgen Receptor Pathway Signaling

NCT01368003 is registered in ClinicalTrials.gov with Toni Choueiri, MD as lead sponsor.

NCT NCT01368003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01368003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Biomarker Study of STA9090 in Castration-Resistant Prostate Cancer (CRPC) With Assessment of Androgen Receptor Pathway Signaling
Lead sponsor
Toni Choueiri, MD
Phase
Phase 2
Overall status
Withdrawn
Start date
April 30, 2011
Completion date
November 30, 2012
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the prostate